Background Endoscopic radiofrequency ablation (RFA) is safe and effective for eradication
of neoplastic Barrett's esophagus (BE). In a minority of cases, however, patients demonstrate …

BACKGROUND & AIMS: Patients with Barrett's esophagus (BE) and high-grade dysplasia
(HGD) or early neoplasia increasingly receive endoscopic mucosal resection and …

Background Stepwise circumferential (Halo 360) and focal (Halo 90) RF ablation (RFA) has
been proven safe and effective for complete eradication of BE. Aim This study reviews the …

Opinion Statement Barrett's esophagus (BE) is the most important risk factor for esophageal
adenocarcinoma. Through the sequence of no dysplasia to low-grade dysplasia (LGD) and …

The management of Barrett's esophagus (BE) has evolved as newer technologies and novel
methods are developed. Endoscopic mucosal resection (EMR) or endoscopic submucosal …

The current standard of treating early Barrett's neoplasia is resection of visible lesions using
endoscopic mucosal resection (EMR) followed by ablative therapy to the Barrett's segment …

Background and Aims A prior randomized study (Surveillance versus Radiofrequency
Ablation study [SURF study]) demonstrated that radiofrequency ablation (RFA) of Barrett's …

Background: Barrett esophagus (BE) containing high-grade dysplasia (HGD) is currently
treated with esophagectomy or PDT entailing considerable morbidity and, in some cases …

Background: Radiofrequency ablation (RFA) has emerged as a leading modality of treating
BE related dysplasia. Safety of RFA has been established in randomized controlled studies …